News: IMC Immuron Partners With Csiro To Produce New Oral Therapeutic For Clinical Evaluation

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    June 19 (Reuters) - Immuron Ltd (IMC) :

    • IMMURON PARTNERS WITH CSIRO TO PRODUCE A NEW ORAL THERAPEUTIC FOR CLINICAL EVALUATION BY THE US DEPARTMENT OF DEFENSE
    • IMMURON LTD - EXECUTES A RESEARCH AGREEMENT WITH HENRY M. JACKSON FOUNDATION FOR ADVANCEMENT OF MILITARY MEDICINE INC
    • IMMURON - NAVAL MEDICAL RESEARCH CENTER SUBMITS PRE-INVESTIGATIONAL NEW DRUG INFORMATION PACKAGE TO FDA
    • IMMURON - NAVAL MEDICAL RESEARCH CENTER PLANS TO FILE IND APPLICATION WITH FDA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.3¢
Change
0.001(1.39%)
Mkt cap ! $19.58M
Open High Low Value Volume
7.3¢ 7.3¢ 7.3¢ $5.189K 71.07K

Buyers (Bids)

No. Vol. Price($)
1 140000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 25000 1
View Market Depth
Last trade - 14.04pm 16/09/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.